ACP-Pharma SRL
ACP-Pharma reported total assets of 48,017 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Sep 2026).
The score of ACP-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ACP-Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 24,290 € |
| Equity | 29,290 € |
| Cash | 422 € |
| EBITDA | 33,918 € |
| Total assets | 48,017 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Sep 2026
ACP-Pharma's financial analysis
- Solvency61.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ACP-Pharma
ACP-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1018.630.058
- VAT number
- BE1018630058
- Peppol
- Registered · 0208:1018630058 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jan 2025
- Registered office
- 1790 Affligem
- Latest accounts
- 2025 · filed on 24 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ACP-Pharma (SRL) has been based in Affligem since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 24,290 € and equity of 29,290 €; its revenue is not published. Its solvency stands at 61.0%, above the median of its sector (44.2%).
Companies similar to ACP-Pharma
Companies in the same business, of comparable size and area, outside its group.
- OVUM Bxl Public relations and communication activities Uccle · balance sheet 776,837 €
- DENM Projects Public relations and communication activities Grimbergen · balance sheet 104,274 €
- Apotheek Veramme - Casier Retail sale of pharmaceutical products Wetteren · balance sheet 614,611 €
- Farmacyze Retail sale of pharmaceutical products Ostend · balance sheet 73,863 €
- Antha Consult Retail sale of pharmaceutical products Liège · balance sheet 272,102 €
- Pharm'Training Lab Retail sale of pharmaceutical products Leuze-en-Hainaut · balance sheet 87,540 €
- Temapharm Retail sale of pharmaceutical products Neupré · balance sheet 191,548 €
- Abocor Retail sale of pharmaceutical products Liège · balance sheet 10,389 €
Frequently asked questions about ACP-Pharma
What is the revenue of ACP-Pharma?
ACP-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ACP-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1018630058 for ACP-Pharma, if the company is VAT-registered. Its company number (CBE) is 1018.630.058.
Where is the registered office of ACP-Pharma?
According to the CBE register, the registered office of ACP-Pharma is in 1790 Affligem.
What is the equity of ACP-Pharma?
At the close of the 2025 financial year, the equity of ACP-Pharma amounts to 29,290 €, a solvency of 61.0% of total assets.
Who manages ACP-Pharma?
The register lists 1 active mandates at ACP-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ACP-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →